Press Release

NeoGenomics Appoints Robert J. Shovlin as Chief Operating Officer

NeoGenomics Schedules its Q3 2014 Earnings Release for October 30, 2014

NeoGenomics Announces Closing of Recent Equity Offering and Exercise in Full of Underwriters' Over-Allotment Option

NeoGenomics Announces Pricing of $32.2 Million Public Offering

NeoGenomics Announces Public Offering of Common Stock

NeoGenomics Reports Record Revenues of $20.7 Million on 40% Test Volume Growth and Expanding Gross Margins for the Second Quarter 2014

NeoGenomics Expands Next Generation Sequencing Services and Offers 23 Different Profiles for Various Hematologic and Solid Cancers

NeoGenomics Completes Acquisition of Path Logic

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients